American Portfolios Advisors’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,675
Closed -$84.2K 3524
2021
Q3
$84.2K Hold
6,675
﹤0.01% 1526
2021
Q2
$103K Buy
6,675
+444
+7% +$7.46K ﹤0.01% 1406
2021
Q1
$126K Sell
6,231
-5,603
-47% -$139K 0.01% 1231
2020
Q4
$320K Buy
11,834
+3,386
+40% +$76K 0.02% 708
2020
Q3
$156K Buy
8,448
+3,038
+56% +$53.9K 0.01% 897
2020
Q2
$96.3K Buy
5,410
+2,523
+87% +$38.4K 0.01% 1016
2020
Q1
$26.6K Buy
2,887
+2,597
+896% +$38.7K ﹤0.01% 1416
2019
Q4
$4.96K Hold
290
﹤0.01% 2287
2019
Q3
$3.02K Buy
290
+10
+4% +$134 ﹤0.01% 2375
2019
Q2
$4.37K Sell
280
-150
-35% -$2.68K ﹤0.01% 2222
2019
Q1
$7.89K Buy
430
+150
+54% +$2.66K ﹤0.01% 1917
2018
Q4
$4.66K Hold
280
﹤0.01% 1902
2018
Q3
$7.9K Hold
280
﹤0.01% 1827
2018
Q2
$7.92K Buy
280
+180
+180% +$5.36K ﹤0.01% 1812
2018
Q1
$3.15K Sell
100
-50
-33% -$1.58K ﹤0.01% 2010
2017
Q4
$4.37K Buy
+150
New +$4.09K ﹤0.01% 1887

Other funds holding CLLS

American Portfolios Advisors's CLLS Position: Q4 2021 in Review

American Portfolios Advisors sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 6,675 shares — an estimated $84.2K sold.

American Portfolios Advisors first reported a position in CLLS in Q4 2017 and held it in 16 quarters. The position peaked at $320K in Q4 2020. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • American Portfolios Advisors reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 6,675 Cellectis shares in Q4 2021, an estimated $84.2K.
  • American Portfolios Advisors first reported a position in Cellectis in Q4 2017 and held it in 16 quarters.
  • American Portfolios Advisors's Cellectis position peaked at $320K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on American Portfolios Advisors's 13F filing for Q4 2021, filed 21 Mar 2023.